CALL, INC. – Trademark Portfolio

Entity Type: 03

CALL, INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PLIXDA. The owner is based in Doylestown, PA.

77 W. Court Street

Doylestown, PA 18901

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CALL, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CALL, INC. have?

CALL, INC. has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 10 abandoned, 5 cancelled.

What trademark classes does CALL, INC. file in?

CALL, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CALL, INC.'s most well-known trademarks?

CALL, INC.'s registered trademark portfolio includes well-known marks such as PLIXDA. These are among 1 currently registered trademark in the portfolio.

What is CALL, INC.'s trademark registration success rate?

CALL, INC. has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.